Ultrasound and alendronate: New tools for osteoporosis screening and treatment

Article Type
Changed
Thu, 04/04/2019 - 10:09
Display Headline
Ultrasound and alendronate: New tools for osteoporosis screening and treatment
Article PDF
Author and Disclosure Information

Richard P. Tonino, MD
Associate Professor of Medicine, University of Vermont College of Medicine; with research interests in the treatment of osteoporosis

Dr. Tonino has performed research that was paid for by the manufacturers of a drug and device discussed in this paper: Merck & Co., Inc. and Hologic, Inc.

Issue
Cleveland Clinic Journal of Medicine - 65(8)
Publications
Page Number
398-401
Sections
Author and Disclosure Information

Richard P. Tonino, MD
Associate Professor of Medicine, University of Vermont College of Medicine; with research interests in the treatment of osteoporosis

Dr. Tonino has performed research that was paid for by the manufacturers of a drug and device discussed in this paper: Merck & Co., Inc. and Hologic, Inc.

Author and Disclosure Information

Richard P. Tonino, MD
Associate Professor of Medicine, University of Vermont College of Medicine; with research interests in the treatment of osteoporosis

Dr. Tonino has performed research that was paid for by the manufacturers of a drug and device discussed in this paper: Merck & Co., Inc. and Hologic, Inc.

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 65(8)
Issue
Cleveland Clinic Journal of Medicine - 65(8)
Page Number
398-401
Page Number
398-401
Publications
Publications
Article Type
Display Headline
Ultrasound and alendronate: New tools for osteoporosis screening and treatment
Display Headline
Ultrasound and alendronate: New tools for osteoporosis screening and treatment
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media